Dominic Cuthbert
News
Positive CHMP recommendation for solriamfetol
The EMA’s Committee for Medical Products for Human Use (CHMP) has adopted a positive opinion recommending solriamfetol to improve wakefulness and reduce excessive daytime...
In brief: Adakveo approved to reduce pain crises in sickle cell disease
Novartis has secured FDA approval for Adakveo (crizanlizumab) to reduce the frequency of pain crises in patients with sickle cell disease.
This is the first...
Amgen & DCRI to evaluate impact of PCSK9 inhibitors on cardiovascular outcomes
Amgen and the Duke Clinical Research Institute (DCRI) have initiated the first large-scale real-world study to assess lipid management and the impact of PCSK9...
